» Articles » PMID: 37031832

Relationship Between the Volume of Cases and In-hospital Mortality in Patients with Cardiogenic Shock Receiving Short-term Mechanical Circulatory Support

Overview
Journal Am Heart J
Date 2023 Apr 9
PMID 37031832
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We examined the relationship between annual case volume at each hospital and outcome in cardiogenic shock (CS) patients receiving mechanical circulatory support (MCS) devices.

Methods: This cross-sectional study used the Japanese nationwide database to identify patients receiving short-term MCS for CS between April 2012 and March 2020. Of 65,837 patients, 3 subcohorts were created; the intra-aortic balloon pump (IABP) alone (n = 48,643), the extracorporeal membrane oxygenation (ECMO) (n = 16,871), and the Impella cohorts (n = 696).

Results: The median annual case volume was 13.5 (7.4-22.1) in the IABP alone cohort, 6.4 (3.4-11.0) in the ECMO cohort, and 7.5 (4.0-10.7) in the Impella cohort. The highest quintile for the volume of cases in the IABP alone and ECMO had the lowest in-hospital mortality (IABP alone, 25.1% in quintile 1 vs 15.2% in quintile 5; ECMO, 73.7% in quintile 1 in 67.4% in quintile 5). Adjusted ORs for in-hospital mortality decreased as case volume increased (IABP alone, 0.63 [0.58-0.68] in quintile 5; ECMO, 0.73 [0.65-0.82] in quintile 5, with the lowest quintile as reference) but did not decrease significantly in the Impella (0.90 [0.58-1.39] in tertile 3, with the lowest tertile as reference). In the continuous models with the case volume as a continuous variable, adjusted ORs for in-hospital mortality decreased to 28 IABP cases/year and 12 ECMO cases/year. They did not decrease or became almost flat above that.

Conclusions: Higher volumes of IABP and ECMO are associated with a lower mortality. There is an upper limit to the decline. Centralizing patients with refractory CS in a particular hospital might improve patient outcomes in each region.

Citing Articles

Can a mechanical circulatory support comprehensive approach to cardiogenic shock at referral centers reduce 30-day mortality?.

Pieri M, Iannaccone M, Burzotta F, Botti G, Aurigemma C, Trani C Front Cardiovasc Med. 2025; 11:1509162.

PMID: 39886617 PMC: 11781227. DOI: 10.3389/fcvm.2024.1509162.


A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery.

Sharma S, Nah J, Siddarth V, Lai H, Liang S, Ong Z Sci Rep. 2024; 14(1):29534.

PMID: 39604501 PMC: 11603185. DOI: 10.1038/s41598-024-81056-z.


Predicting survival after Impella implantation in patients with cardiogenic shock: The J-PVAD risk score.

Kondo T, Yoshizumi T, Morimoto R, Imaizumi T, Kazama S, Hiraiwa H Eur J Heart Fail. 2024; 27(1):51-59.

PMID: 39300761 PMC: 11798632. DOI: 10.1002/ejhf.3471.


Epidemiology of ischemic stroke and hemorrhagic stroke in venoarterial extracorporeal membrane oxygenation.

Hwang J, Kalra A, Shou B, Whitman G, Wilcox C, Brodie D Crit Care. 2023; 27(1):433.

PMID: 37946237 PMC: 10633935. DOI: 10.1186/s13054-023-04707-z.